| |  Online-Ressource |
|---|
| Verfasst von: | Kriegsmann, Katharina [VerfasserIn]  |
|---|
| | Manta, Calin-Petru [VerfasserIn] |
|---|
| | Schwab, Ricarda [VerfasserIn] |
|---|
| | Mai, Elias K. [VerfasserIn] |
|---|
| | Raab, Marc-Steffen [VerfasserIn] |
|---|
| | Salwender, Hans J. [VerfasserIn] |
|---|
| | Fenk, Roland [VerfasserIn] |
|---|
| | Besemer, Britta [VerfasserIn] |
|---|
| | Dürig, Jan [VerfasserIn] |
|---|
| | Schroers, Roland [VerfasserIn] |
|---|
| | von Metzler, Ivana [VerfasserIn] |
|---|
| | Hänel, Mathias [VerfasserIn] |
|---|
| | Mann, Christoph [VerfasserIn] |
|---|
| | Asemissen, Anne M. [VerfasserIn] |
|---|
| | Heilmeier, Bernhard [VerfasserIn] |
|---|
| | Bertsch, Uta [VerfasserIn] |
|---|
| | Huhn, Stefanie [VerfasserIn] |
|---|
| | Müller-Tidow, Carsten [VerfasserIn] |
|---|
| | Goldschmidt, Hartmut [VerfasserIn] |
|---|
| | Hundemer, Michael [VerfasserIn] |
|---|
| Titel: | Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM |
|---|
| Verf.angabe: | Katharina Kriegsmann, Calin Manta, Ricarda Schwab, Elias K. Mai, Marc S. Raab, Hans J. Salwender, Roland Fenk, Britta Besemer, Jan Dürig, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Anne M. Asemissen, Bernhard Heilmeier, Uta Bertsch, Stefanie Huhn, Carsten Müller-Tidow, Hartmut Goldschmidt, and Michael Hundemer |
|---|
| E-Jahr: | 2023 |
|---|
| Jahr: | January 27, 2023 |
|---|
| Umfang: | 5 S. |
|---|
| Fussnoten: | Gesehen am 23.03.2023 |
|---|
| Titel Quelle: | Enthalten in: Blood advances |
|---|
| Ort Quelle: | Washington, DC : American Society of Hematology, 2016 |
|---|
| Jahr Quelle: | 2023 |
|---|
| Band/Heft Quelle: | 7(2023), 3 vom: Jan., Seite 379-383 |
|---|
| ISSN Quelle: | 2473-9537 |
|---|
| Abstract: | TO THE EDITOR: In multiple myeloma (MM), measurable residual disease (MRD) is defined as a low-level detection of malignant plasma cells (PCs) that persist after treatment. MM MRD from bone marrow (BM) compartment characterizes the treatment efficacy, is highly predictive for outcome, and was therefore introduced as a consensus criterion for response assessment.1,2 While BM aspirate is considered the primary source of sample for MM MRD assessment, this technique is challenging in terms of repeated BM punctures, dilution by peripheral blood (PB), extramedullary disease, and heterogenous MM tumor spread throughout the BM compartment.3 To overcome these obstacles, MM MRD detection in PB samples was established.4,5 Recent studies have demonstrated that circulating malignant PCs can be detected by next-generation flow cytometry (NGF) at first diagnosis (FD) of MM.6 Circulating malignant PC detection by NGF after treatment is challenging, particular due to low frequency of malignant PCs circulating in the PB, and lacks additional studies with a sufficient number of patients.7-9 |
|---|
| DOI: | doi:10.1182/bloodadvances.2022008005 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1182/bloodadvances.2022008005 |
|---|
| | DOI: https://doi.org/10.1182/bloodadvances.2022008005 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| K10plus-PPN: | 1839868007 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM / Kriegsmann, Katharina [VerfasserIn]; January 27, 2023 (Online-Ressource)
